Quick Answer
Addiction is a chronic brain condition, not a moral failing. Learn how substance use disorders develop and what evidence-based recovery pathways look like.
Medically reviewed by Dr. Ruja Shrestha • NMC 19766 • Kathmandu Neurology Clinic & Cognitive Center
Substance Use Disorder (SUD) is a chronic medical condition characterized by compulsive substance use despite harmful consequences. The DSM-5 defines SUD as a problematic pattern of use leading to clinically significant impairment or distress, manifested by a combination of symptoms including loss of control over use, cravings, tolerance (needing increasing amounts for the same effect), withdrawal symptoms when the substance is discontinued, and continued use despite knowledge of physical or psychological harm. SUDs are classified as mild, moderate, or severe based on the number of diagnostic criteria met.
Addiction affects the brain's reward circuitry, particularly the mesolimbic dopamine pathway. Repeated substance use leads to neuroadaptations — changes in neurotransmitter systems, receptor density, and neural circuit function — that alter the brain's response to natural rewards and strengthen compulsive drug-seeking behavior. Over time, the initial pleasurable effects of substance use diminish (tolerance and anhedonia), and the substance becomes necessary to avoid withdrawal and feel normal. This transition from positive reinforcement (using for pleasure) to negative reinforcement (using to avoid discomfort) is a hallmark of the addiction cycle.
Dr. Ruja Shrestha — consultant psychiatrist & cbt therapist at Kathmandu Neurology Clinic & Cognitive Center provides evidence-based evaluation for substance use disorder.
Common substances associated with SUDs include alcohol, tobacco, cannabis, opioids (heroin, prescription painkillers), stimulants (cocaine, methamphetamine), benzodiazepines, hallucinogens, and inhalants. Behavioral addictions — such as gambling disorder, which is classified alongside SUDs in the DSM-5 — share many neurobiological and behavioral features with substance addictions.
Risk factors for developing SUDs include genetic vulnerability (heredity accounts for approximately 40 to 60 percent of addiction risk), early exposure to substances, co-occurring mental health conditions (depression, anxiety, PTSD, ADHD), adverse childhood experiences, peer influence, and social and environmental factors including poverty and lack of access to education and employment.
Treatment of SUDs is evidence-based and typically involves a combination of approaches. Detoxification and withdrawal management address the acute physiological effects of substance discontinuation and should be medically supervised for substances with potentially dangerous withdrawal syndromes (alcohol, benzodiazepines, opioids). Medication-Assisted Treatment (MAT) uses FDA-approved medications to reduce cravings, prevent relapse, and support recovery. For opioid use disorder, methadone, buprenorphine, and naltrexone have strong evidence. For alcohol use disorder, naltrexone, acamprosate, and disulfiram are options. For tobacco dependence, nicotine replacement therapy, varenicline, and bupropion are evidence-based pharmacotherapies.
Behavioral therapies are central to addiction treatment. CBT for substance use disorders helps individuals identify triggers, develop coping strategies, and modify maladaptive thought patterns. Motivational Interviewing (MI) addresses ambivalence about change and strengthens intrinsic motivation. Contingency Management uses tangible reinforcers to reward abstinence and treatment adherence. Community Reinforcement Approach focuses on making abstinence more rewarding than substance use by modifying environmental factors.
Twelve-step programs (Alcoholics Anonymous, Narcotics Anonymous) and other mutual-support groups provide peer support, accountability, and a framework for recovery. While not a formal medical treatment, research supports their effectiveness, particularly when combined with professional treatment. SMART Recovery is an evidence-based alternative that uses CBT and motivational techniques.
Recovery from addiction is understood as a long-term process that may involve multiple treatment episodes. Relapse is not uncommon and does not represent treatment failure — it is often part of the recovery journey. Relapse prevention strategies include identifying high-risk situations, developing coping plans, maintaining social support, addressing co-occurring mental health conditions, and ongoing aftercare participation.
In Nepal, alcohol use disorder is prevalent, with significant public health consequences. Illicit substance use, including cannabis and opioids, also presents challenges. Cultural attitudes toward alcohol use vary, and harmful drinking patterns may be normalized in certain social contexts. Treatment infrastructure for SUDs is limited, particularly outside urban areas. Access to MAT, trained addiction counselors, and residential treatment programs is restricted. Stigma associated with addiction is a major barrier to help-seeking.
This article is educational and does not replace individual medical advice. If you or someone you know is struggling with substance use, consult a qualified healthcare professional for assessment and treatment planning.
**Frequently Asked Questions**
Q: Does a person need to hit rock bottom before they can recover? A: No. Early intervention improves outcomes. Waiting for a crisis point can increase the risk of serious health consequences, legal problems, or death. Treatment can be effective at any stage.
Q: Is addiction a choice or a disease? A: The initial decision to use a substance may be voluntary, but repeated use leads to neurobiological changes that impair the ability to control use. Major medical organizations, including the American Medical Association and the American Society of Addiction Medicine, classify addiction as a chronic brain disorder.
Q: Can someone recover from addiction without professional help? A: Some individuals do recover without formal treatment, but the evidence supports that professional intervention — combined with mutual support — produces better long-term outcomes, particularly for severe addiction or addiction to certain substances.
Frequently asked questions
Answers reviewed by Dr. Jitendra Prasad Yadav • MBBS, MD (Internal Medicine), FICN (Neurology), FCNV, FIHM • NMC 8029
SUD is a chronic medical condition involving changes in brain circuits related to reward, stress, and self-control. While initial use may be voluntary, continued use alters brain function, making stopping difficult without support.
Medication options depend on the substance. For alcohol: naltrexone, acamprosate, disulfiram. For opioids: buprenorphine, methadone, naltrexone. For tobacco: nicotine replacement, varenicline, bupropion. These medications are evidence-based and reduce relapse risk.
Migraine is a neurological condition; headache is one feature. Associated symptoms and functional impact are important for diagnosis.
Aura refers to visual, sensory, or speech symptoms that precede the headache in some people. Both types are migraine; the presence of aura may influence management discussion.
More: All FAQs → · Ask Dr. Jitendra →
Related articles
When to See a Psychiatrist: Recognizing the Signs That Professional Help Is Needed
Practical guidance on recognizing when mental health symptoms warrant professional psychiatric evaluation, what to expect during a first appointment, and how to prepare.
Obsessive-Compulsive Disorder: Understanding Its Impact on Daily Life
How OCD manifests in everyday routines, the distinction between obsessions and compulsions, and what current evidence says about effective treatments.
Bipolar Disorder Explained: Mania, Depression, and Managing the Cycle
An overview of bipolar disorder — the distinction between Bipolar I and Bipolar II, the nature of manic and depressive episodes, and current treatment approaches.
Medical Disclaimer
Content on this website is for general educational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified healthcare professional. Always seek the advice of your physician or other qualified provider with any questions regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this website. In case of a medical emergency, contact emergency services immediately. No doctor–patient relationship is established by use of this site or by contacting the clinic through the site.
References & Review
Reviewed by Dr. Jitendra Prasad Yadav • Last reviewed: 2026-09-04
- International Classification of Headache Disorders, 3rd edition (ICHD-3).
- Harrison's Principles of Internal Medicine — Neurology sections.
- American Academy of Neurology guidelines for selected conditions (where applicable).
Content is educational and aligns with standard medical references; individual evaluation may vary. External links provide context and do not imply endorsement.